NMIBC are reported as genomically stable tumors characterized by FGFR3 mutations or chromosomal translocations (in around 70% of low-grade tumors) [27,28], which may contribute to early urothelial hyperplasia [29]. This evidence concerns the gene FGFR3 and urothelial hyperplasia.